Danish court clears drug firm of blood contaminationBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6979.552 (Published 04 March 1995) Cite this as: BMJ 1995;310:552
The Danish Haemophiliacs Association is considering an appeal to the European Court of Human Rights after a court ruling on who should bear responsibility for eight of its members who became infected with HIV after using contaminated blood products in the early 1980s.
After a seven year struggle to get the case to court the judges ruled that officials from the Health Ministry and the National Health Board, as well as the country's largest drugs manufacturer, Novo Nordisk, which supplied the factor VIII, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial